process for making a dry and stable hesostatic composition, method for dispensing a hemostatic composition to a target site on a patient's body, final finished container, method for providing a ready-to-use hemostatic composition, and kit for administering a hemostatic composition

• 收藏
• 分享

专利权人:

BAXTER INTERNATIONAL INC.;BAXTER HEALTHCARE S.A.

发明人:

ANDREAS GOESSL,ATSUSHI EDWARD OSAWA,CARY J. REICH

申请号：

BR112012030455

公开号：

BR112012030455A2

申请日:

2011.06.01

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

A process for making a dry and stable hesostatic composition, a method for dispensing a hemostatic composition to a target site, a finished finished container, a method for providing a ready-to-use hemostatic composition, and a kit for administering a hemostatic composition is described. a dry and stable hemostatic composition, said process comprising a) providing a first component comprising a dry preparation of a coagulation inducing agent, b) providing a second component comprising a dry preparation of a biocompatible polymer suitable for use in hemostasis, c) providing said first component and said second component in a combined form in a final container, c1) either by filling said first component and said second component in said final container to obtain a dry mixture in said final container, c2) or providing said first component or referred to of said component in said final container and adding said second component or said first component to obtain a combination of said first component with said second component in said final container d) finishing the final container for a storable pharmaceutical device containing said first component and said second component in a combined form as a dry and stable hemostatic composition.processo para fabricar uma composição hesmostática seca e estável, método para dispensar uma composição hemostática a um sítio alvo, recipiente acabado final, método para prover uma composição hemostática pronta para uso, e, kit para administra uma composição hemostática descreve-se um processo para fabricar uma composição hemostática seca e estável, referido processo compreendendo a) prover um primeiro componente compreendendo uma preparação seca de um agente de indução de coagulação, b) prover um segundo componente compreendendo uma preparação seca de um polímero biocompatível apropriado para uso em hemostase, c) prover referido primeiro componente e referido segundo componente em uma forma combinada em um recipiente final , c1) quer enc

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/